Lewis H. Bender's most recent trade in Intensity Therapeutics Inc was a trade of 700,000 Stock Option (right to buy Common Stock) done . Disclosure was reported to the exchange on May 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intensity Therapeutics Inc | Lewis H. Bender | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 700,000 | 700,000 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | Lewis H. Bender | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 464,805 | 464,805 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | Lewis H. Bender | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 33,574 | 33,574 | - | - | Stock Option (right to buy Common Stock) |